Jane Street’s Cardiff Oncology CRDF Stock Holding History

Jane Street’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,500	Closed	-$21.6K	–	11293
2025 Q3	$21.6K	Buy	+10,500	New	+$29K	﹤0.01%	10521
2021 Q4	–	Sell	-35,400	Closed	-$236K	–	10149
2021 Q3	$236K	Buy	35,400 +21,400	+153%	+$134K	﹤0.01%	8611
2021 Q2	$93K	Buy	+14,000	New	+$119K	﹤0.01%	9295
2021 Q1	–	Sell	-17,300	Closed	-$311K	–	9143
2020 Q4	$311K	Sell	17,300 -28,600	-62%	-$503K	﹤0.01%	6346
2020 Q3	$651K	Buy	+45,900	New	+$303K	﹤0.01%	4763

Other funds holding CRDF

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jane Street's CRDF Position: Q2 2026 in Review

Jane Street increased its Cardiff Oncology (CRDF) stake by 1,416% in Q2 2026, buying an estimated $901K and bringing the position to 607,900 shares worth $790K. The position accounts for ﹤0.01% of the portfolio, ranked #7026.

Jane Street first reported a position in CRDF in Q4 2016 and has held it in 15 quarters since. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

Jane Street held 607,900 shares of Cardiff Oncology worth $790K as of Q2 2026.
Jane Street bought 567,795 Cardiff Oncology shares in Q2 2026, an estimated $901K.
Cardiff Oncology made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7026 holding.
Jane Street first reported a position in Cardiff Oncology in Q4 2016 and has held it in 15 quarters since.
105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.